High-dose methotrexate in adults with osteosarcoma: a population pharmacokinetics study and validation of a new limited sampling strategy-Reference-Cited by-同舟云学术

High-dose methotrexate in adults with osteosarcoma: a population pharmacokinetics study and validation of a new limited sampling strategy

Published:2008-03 Issue:3 Volume:19 Page:267-273
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Dupuis Charlotte,Mercier Cedric,Yang Chenguang,Monjanel-Mouterde Suzanne,Ciccolini Joseph,Fanciullino Raphaelle,Pourroy Bertrand,Deville Jean-Laurent,Duffaud Florence,Bagarry-Liegey Danielle,Durand Alain,Iliadis Athanassios,Favre Roger

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference30 articles.

1. Primary osteogenic sarcoma: the rationale for preoperative chemotherapy and delayed surgery;Rosen;Cancer,1979

2. Neoadjuvant chemotherapy for osteogenic sarcoma: results of a cooperative German/Austrian study;Winkler;J Clin Oncol,1984

3. High-dose methotrexate pharmacokinetics and outcome of children and young adults with osteosarcoma;Crews;Cancer,2004

4. Methotrexate pharmacokinetics and survival in osteosarcoma;Aquerreta;Pediatr Blood Cancer,2004

5. Predictive factors of histologic response to primary chemotherapy in osteosarcoma of the extremity: study of 272 patients preoperatively treated with high-dose methotrexate, doxorubicin, and cisplatin;Bacci;J Clin Oncol,1998

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anticipating Leucovorin Rescue Therapy in Patients with Osteosarcoma through Methotrexate Population Pharmacokinetic Model;Pharmaceutics;2024-09-06

2. An interactive dose optimizer based on population pharmacokinetic study to guide dosing of methotrexate in Chinese patients with osteosarcoma;Cancer Chemotherapy and Pharmacology;2024-08-24

3. Development of a novel nomogram for predicting delayed methotrexate excretion following high-dose methotrexate in adult patients with hematologic malignancies;Cancer Chemotherapy and Pharmacology;2024-06-21

4. Development of a novel nomogram for predicting delayed methotrexate excretion following high-dose methotrexate in adult patients with hematologic malignancies;2024-02-28

5. Understanding hemoglobin contribution to high-dose methotrexate disposition—population pharmacokinetics in pediatric patients with hematological malignancies;European Journal of Clinical Pharmacology;2024-02-12